Marimed (MRMD) Change in Accured Expenses (2011 - 2026)

Marimed (MRMD) has reported Change in Accured Expenses for 16 consecutive years, with -$81000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 71.17% year-over-year to -$81000.0 in Q2 2026; TTM through Jun 2026 was $2.3 million, a 4.28% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, up 80.27% from the prior year.
• Change in Accured Expenses was -$81000.0 for Q2 2026 at Marimed, down from $829000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $1.9 million in Q1 2025 and troughed at -$1.7 million in Q4 2023.
• A 5-year average of $185666.7 and a median of -$108500.0 in 2024 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses tumbled 491.0% in 2023 and soared 627.05% in 2024, its largest moves.
• Over 5 years, Change in Accured Expenses stood at -$289000.0 in 2022, then plunged by 491.0% to -$1.7 million in 2023, then soared by 39.58% to -$1.0 million in 2024, then soared by 125.1% to $259000.0 in 2025, then tumbled by 131.27% to -$81000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$81000.0 (Q2 2026), $829000.0 (Q1 2026), and $259000.0 (Q4 2025), per Business Quant data.